View Press Releases
-
Medical device outsourcing market to hit $50.37 bn in 2020
SAN FRANCISCO, CA - Nov 21, 2014 - Global medical device outsourcing market is expected to reach USD 50.37 billion by 2020, according to a new study by Grand View Research, Inc
Nov 20, 2014
-
Electrophysiology Devices Market Worth USD 6.19 billion By 2020
SAN FRANCISCO, CA - Nov 21, 2014 - Global electrophysiology devices market is expected to reach USD 6.19 billion by 2020, according to a new study by Grand View Research, Inc
Nov 21, 2014
-
What next for Health in Food? Consumer Lifestyles, Nutrition, Food Labelling and Product Choice
SAN FRANCISCO, CA - Nov 20, 2014 - Synopsis
Nov 20, 2014
Disease-related, demographic, and desire-led drivers are making health of growing importance to food marketers
-
The Solubility Fragment Library from OTAVA Ltd.
VAUGHAN, ON - Nov 20, 2014 - The aqueous solubility of fragments is often a limiting factor for biophysical techniques used in fragment-based drug design (FBDD) such as nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), X-ray diffraction (XRD), high concentration analysis (HCA) etc
Nov 20, 2014
-
Certara Updates its Simcyp Simulator Used to Predict Drug Behavior in Virtual Patient Populations
PRINCETON, NJ - Nov 19, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has released version 14 of its Simcyp Population-based Simulator, which enables biopharmaceutical researchers to predict drug-drug interactions and pharmacokinetic-pharmacodynamic (PK-PD) outcomes in virtual human and animal populations
Nov 19, 2014
-
Lab7 Systems launches BioBuilds.org to host a major expansion of BioBuilds, a curated and versioned repository for Open Source bioinformatics tools
AUSTIN, TX - Nov 19, 2014 - Lab7 Systems, Inc., the developer of the Enterprise Sequencing Platform for the management of next-generation genome sequencing (NGS) data and workflows, has announced BioBuilds 2014
Nov 19, 2014
-
Definiens Predicts Biggest Drivers for Personalized Medicine in 2015: Data Quality, Immunotherapy, Combination Treatments and Predictive Biomarkers
MUNICH, GERMANY - Nov 18, 2014 - Major opportunities are on the horizon for personalized medicine and clinical cancer research and treatment, according to Definiens, the global leader in Tissue Phenomics® for oncology diagnostics
Nov 18, 2014
-
Medidata Collaborates with GlaxoSmithKline on Mobile Health Initiative to Test Novel Technology for Clinical Trial Optimization
NEW YORK, NY, UNITED STATES OF AMERICA - Nov 17, 2014 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced the completion of a method development project conducted in partnership with GlaxoSmithKline plc (GSK) to evaluate the impact of unifying mobile health (mHealth) devices with cloud-based technologies in a clinical trial setting
Nov 17, 2014
-
11beta-HSD1 focused library from OTAVA
VAUGHAN, ON - Nov 14, 2014 - 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1, 11beta-HSD1) is an NADPH-dependent enzyme, which catalyses conversion of inactive glucocorticoids 11-dehydrocorticosterone and cortisone to active corticosterone and cortisol and vice versa
Nov 13, 2014
-
ARUP Laboratories and PierianDx Create Partnership to Produce More Efficient and Effective Diagnostic Genetic Tests
SALT LAKE CITY AND ST LOUIS, MO, US - Nov 12, 2014 - ST LOUIS and SALT LAKE CITY (Nov. 12, 2014) – ARUP Laboratories and PierianDx announced today a partnership that will result in faster and more efficient diagnostic genetic testing for thousands of patients across the U
Nov 12, 2014
-
CREBBP focused library from OTAVA
- Nov 7, 2014 - CREB-binding protein (CREBBP, CBP) is a transcriptional coactivator of a broad range of transcription factors
Nov 6, 2014
-
MolecularHealth to Speak at the 10th Annual Personalized Medicine Conference
THE WOODLANDS, TX, UNITED STATES - Nov 6, 2014 - MolecularHealth announced today that Medical Director Gabriel Bien-Willner, M.D., Ph.D., will speak at this years Personalized Medicine Conference
Nov 6, 2014
-
Know More about Single-Cell Sequencing to Achieve More Biology Findings
SHIRLEY, NY - Nov 5, 2014 - As cell is the basic unit of biology, more and more scientists are trying to separate, study and compare cells
Nov 5, 2014
-
Takara Bio Selects Genedata Software to Automate and Standardize NGS Data Analysis
TOKYO, JAPAN - Nov 5, 2014 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that Takara Bio Inc
Nov 7, 2014
-
Cloud Pharmaceuticals Announces World-Class Board of Directors
RESEARCH TRIANGLE PARK, UNITED STATES - Nov 5, 2014 - Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it ratified its board of directors at its annual meeting on September 16, 2014
Nov 4, 2014
-
PRESS RELEASE: NEW STARTUP ‘BIO DATA BRIDGES’ OFFERS LAB DATA MANAGEMENT HEALTH CHECK™
SEATTLE, WA - Nov 4, 2014 - The challenge of future-proofing scientific data systems just got a lot easier for life science companies
Nov 4, 2014
-
SRA Joins the Global Alliance for Genomics and Health
NEW YORK, NY - Nov 4, 2014 - SRA International, Inc., a leading provider of IT solutions and professional services to government organizations, announced that it has joined the Global Alliance for Genomics and Health (Global Alliance) as an Organizational Member
Nov 7, 2014
-
Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring
NEW YORK, NY - Nov 4, 2014 - Medidata (NASDAQ: MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), today announced they are expanding their partnership to provide the life science industry with a more comprehensive approach to risk-based monitoring (RBM)—aimed at conducting drug development more intelligently, more quickly and more cost-effectively
Nov 7, 2014
-
Certara Updates Its Industry-Leading PK/PD Phoenix Platform and Introduces Phoenix Quantum Packages for Enhanced Collaboration and Efficiency
PRINCETON, NJ - Nov 3, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch of version 1
Nov 3, 2014
-
A Brief Introduction of Creative Animodel’s Bioanalysis
SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products
Nov 3, 2014